Literature DB >> 8573780

Progressive multifocal leukoencephalopathy: a review of the pathology and pathogenesis.

A J Aksamit1.   

Abstract

Progressive multifocal leukoencephalopathy is an important viral opportunistic infection of oligodendrocytes leading to direct demyelination. Virus is likely disseminated to the brain via the blood. However, the timing of that dissemination with relationship to clinical disease is unknown. Important clues about viral pathogenesis have been learned by applying molecular in situ techniques to diseased brain. The oligodendrocyte is the primary target for JC virus infection, and its death is the primary reason for demyelination. Bizarre astrocytes show limited viral DNA replication but are abortively infected. Although lymphoid organs can be infected by JC virus, there is no definitive evidence that lymphoid cells carry virus into the brain at the time of immunosuppression. JC virus may be reactivated from a latent state in both the brain and in non-central nervous system (CNS) organs at the time of immunosuppression, leading to clinical disease. Future sensitive in situ studies will likely resolve controversies about pathogenesis.

Entities:  

Mesh:

Year:  1995        PMID: 8573780     DOI: 10.1002/jemt.1070320405

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  14 in total

1.  Use of diffusion-weighted imaging to evaluate the initial response of progressive multifocal leukoencephalopathy to highly active antiretroviral therapy: early experience.

Authors:  C Buckle; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

2.  Human glial chimeric mice reveal astrocytic dependence of JC virus infection.

Authors:  Yoichi Kondo; Martha S Windrem; Lisa Zou; Devin Chandler-Militello; Steven J Schanz; Romane M Auvergne; Sarah J Betstadt; Amy R Harrington; Mahlon Johnson; Alexander Kazarov; Leonid Gorelik; Steven A Goldman
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

3.  Deep-Sequence Identification and Role in Virus Replication of a JC Virus Quasispecies in Patients with Progressive Multifocal Leukoencephalopathy.

Authors:  Kenta Takahashi; Tsuyoshi Sekizuka; Hitomi Fukumoto; Kazuo Nakamichi; Tadaki Suzuki; Yuko Sato; Hideki Hasegawa; Makoto Kuroda; Harutaka Katano
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

4.  Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS.

Authors:  Ruangang Pan; Qinran Zhang; Scott M Anthony; Yu Zhou; Xiufen Zou; Martin Cassell; Stanley Perlman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

5.  Acute and persistent infection of human neural cell lines by human coronavirus OC43.

Authors:  N Arbour; G Côté; C Lachance; M Tardieu; N R Cashman; P J Talbot
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

Review 6.  The role of polyomaviruses in human disease.

Authors:  Mengxi Jiang; Johanna R Abend; Silas F Johnson; Michael J Imperiale
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

Review 7.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

8.  Progressive multifocal leukoencephalopathy.

Authors:  Allen J Aksamit
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

9.  Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy.

Authors:  Sergio Piña-Oviedo; Katarzyna Urbanska; Sujatha Radhakrishnan; Thersa Sweet; Krzysztof Reiss; Kamel Khalili; Luis Del Valle
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

Review 10.  Polyomaviruses of nonhuman primates: implications for research.

Authors:  Meredith A Simon
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.